Related Experiment Videos

Subcellular actions and potential adverse cardiac effects of the cardiotonic ionophore monensin

Insights

Monensin enhances heart muscle contraction at therapeutic doses but can cause severe issues when combined with other drugs, impacting cardiac function and mitochondria.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pharmacology

Background:

  • Monensin is an ionophore with known effects on cellular ion transport.
  • Its impact on cardiac function and mitochondrial respiration requires detailed investigation.

Purpose of the Study:

  • To investigate the effects of monensin on cardiac contractility and cellular ion balance.
  • To assess the impact of monensin on mitochondrial function and its interaction with other cardiac drugs.

Main Methods:

  • Electrically driven rabbit left atria were used to study monensin's inotropic effects.
  • Canine myocardial Na+mK+-adenosine triphosphatase activity was measured.
  • Isolated rabbit heart mitochondria were used to assess monensin's effects on respiration.

Main Results:

  • Monensin (0.5–30 microM) produced dose-dependent positive inotropy in rabbit atria without contracture.
  • Combining monensin with low-dose ouabain led to contracture or irregular responses, suggesting intracellular Na+ and Ca++ overload.
  • Monensin ( >10 nM) inhibited ADP-stimulated mitochondrial respiration and respiratory control ratios, with significant effects at 1 microM.

Conclusions:

  • Monensin increases cardiac contractility at concentrations that do not cause toxicity in intact atrial tissue.
  • Monensin's interaction with ouabain highlights potential risks of combined drug use due to ion overload.
  • Monensin significantly impairs mitochondrial respiration, suggesting a potential mechanism for cardiac dysfunction at higher concentrations.

Related Concept Videos